NEW YORK, April 11 - The US government has awarded Cepheid a patent for its I-CORE technology, which allows for "simultaneous, real-time optical excitation and detection of two or more nucleic acids," and one for a technology that allows for the "automated preparation of biological samples using chip-based microfluidics technology."

To date, Cepheid has 36 US patents either issued or pending, plus corresponding foreign patent applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.